Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
作者信息
Siscos Spyros M, Neill Brett C, Seger Edward W, Rajpara Anand, Hocker Thomas L H
机构信息
Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas.
Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas.
出版信息
J Am Acad Dermatol. 2021 Mar;84(3):833-835. doi: 10.1016/j.jaad.2020.09.081. Epub 2020 Oct 3.
PMID:33022309
Abstract
摘要
相似文献
1
Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
J Am Acad Dermatol. 2021 Mar;84(3):833-835. doi: 10.1016/j.jaad.2020.09.081. Epub 2020 Oct 3.
2
The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Dermatol Surg. 2020 Oct;46(10):1267-1271. doi: 10.1097/DSS.0000000000002645.
3
Mohs Micrographic Surgery for the Treatment of Melanoma: A Cross-Sectional Survey on the Barriers, Prevalence, and Practice.
Dermatol Surg. 2021 Aug 1;47(8):1114-1115. doi: 10.1097/DSS.0000000000002933.
4
Utilization Patterns of Fellowship-Trained Mohs Surgeons in the Treatment of Melanoma in Situ and Melanoma.
Dermatol Surg. 2021 Jun 1;47(6):814-815. doi: 10.1097/DSS.0000000000002668.
5
Factors Deterring the Utilization of Mohs Surgery for Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Dermatol Surg. 2021 May 1;47(5):709-710. doi: 10.1097/DSS.0000000000002711.
6
Syringotropic Melanoma Identified During Mohs Micrographic Surgery.
Dermatol Surg. 2021 Jun 1;47(6):836-837. doi: 10.1097/DSS.0000000000002863.
7
Mohs micrographic surgery for melanoma: A prospective multicenter study.
J Am Acad Dermatol. 2019 Sep;81(3):767-774. doi: 10.1016/j.jaad.2019.05.057. Epub 2019 May 28.
8
Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
J Am Acad Dermatol. 2021 Jan;84(1):196-198. doi: 10.1016/j.jaad.2020.04.086. Epub 2020 Apr 25.
9
Comparison of staged excision and Mohs micrographic surgery with and without MART-1 immunostains for surgical treatment of melanoma of the head, neck, and special sites: A retrospective cohort study.
J Am Acad Dermatol. 2021 Jan;84(1):192-194. doi: 10.1016/j.jaad.2020.04.081. Epub 2020 Apr 26.
10
Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
J Am Acad Dermatol. 2018 Dec;79(6):1109-1116.e1. doi: 10.1016/j.jaad.2018.06.058. Epub 2018 Jul 10.
引用本文的文献
1
Disease-specific survival of malignant melanoma after Mohs micrographic surgery is not impacted by initial margins: A systematic review and meta-analysis.
JAAD Int. 2023 Jun 28;13:140-149. doi: 10.1016/j.jdin.2023.06.009. eCollection 2023 Dec.
Zotero 插件